eCourses are individual online courses from renowned presenters at our live conferences. Learn via audio or video, receive the supporting materials, and fulfill MCLE requirements at your convenience with the best content available!
These courses are CLE accredited in Texas and California, with some accredited in Oklahoma.
If you need credit for an eCourse in other states please read through the disclaimerbefore purchasing an eCourse to make sure you will be able to self-report your MCLE credit after completion of the eCourse
Best practices for establishing and maintaining a healthy relationship between in-house and outside counsel, including effective communications, working with business leaders and inventors, establishing working procedures, activities beyond the business relationship, creating unique service offerings, and relevant ethical issues. more »
Session 1: Year in Review: Federal Circuit and SCOTUS Update - A whirlwind summary of the most important developments in Supreme Court and Federal Circuit case law over the last year.
Session 2: Recent Developments in Claims Construction - The baseline of patent application preparation/prosecution, district court trials, Federal Circuit appeals, and AIA post-grant review proceedings, is claim construction. Review of important 2018/2019 claim construction cases and issues at the Federal Circuit and trial court levels, as well as at the PTAB. And examine the PTAB’s procedural and substantive claim construction “rules, practices, and etc.," including the PTAB’s adoption of Phillips construction under all circumstances, and rule and practice changes to mandate PTAB consideration of claim constructions from other proceedings.
Session 3: Judicial Panel - Hear distinguished judges from the District Courts discuss their experiences hearing and trying patent more »
Session 1: Recidivist Debtors: Chapter 22s of Oil and Gas Business Debtors. Why Is it Happening Now? - A discussion about the recent influx of repeat chapter 11 debtors, factors causing distress in the oil and gas industry, and best practices in chapter 22 cases.
Session 2: Modifying Labor and Retirement Obligations in Bankruptcy - Hear how companies may use sections 1113 and 1114 of the Bankruptcy Code to modify labor, retiree and other employee “legacy” obligations in chapter 11. The panelists, who have represented companies and other creditors in bankruptcy cases involving these topics as counsel and investment banker, share lessons learned from recent transactions.
Session 3: Rights Offerings - Use and Impact - Rights offerings are often consummated in complex chapter 11 cases to raise equity upon exiting bankruptcy. While rights offerings are beneficial to the debtor and often non-controversial, issues can emerge in terms of opportunity to participate, fees charged, and impact on non-participating parties.
Session 4: Beyond E-Commerce: Root Causes of the Retail Crisis - Examine the drivers of the recent turmoil in the retail industry. How much worse can it get and how long will it continue?
Session 5: Utilizing and Interpreting Make Whole Provisions, including Practical Lessons for Deal Structure - A discussion of make whole provisions including a primer on what they are and their intended purpose, an overview of their interpretation under various states’ laws, and consideration of how to successfully utilize them in the event of a bankruptcy. more »
In the aftermath of recent news of lawyers being indicted for extortion in the negotiation process and recent bankruptcy court decisions referring lawyers to the authorities, explore the contours of ethical negotiations, illegal extortion, and bankruptcy bribery. more »
The world of social media has engulfed us all. Not only has it transformed our society, but it has worked its way into every legal field as well. Discover the ethical issues facing you as attorneys—and that of your clients—in this social media age. more »
THIS MONTH: Do's and Don'ts of Discovery in Texas Civil Proceedings • What’s Going on at the Southern Border: Immigrants’ Rights Issues in Texas • Indeliberate Practice: How the Business of Law Will Make You Mediocre (If You Let It) • Employee Mental Health Accommodations: Tips for Success in Managing Stigma and Stress • Financial Powers of Attorney: Do You Want Fries With That Will? • Pro Bono Collaborations with Outside Counsel: The New Networking more »
Session 1: General Session ABI Report Review - A high octane speedy review of the suggestions made by the ABI Commission on Consumer Bankruptcy that could affect your practice.
Session 2: ABI Consumer Commission Report - Focus on the Commission’s specific recommendations on: reserve funds in chapter 13 cases, student loans, racial justice, “dirt for debt” plans, repeat filers, the notice of final cure process, attorney competency and compensation, and chapter 13 debt limits.
Session 3: Litigation In Consumer Cases - Explore litigation considerations before, during and after bankruptcy, including forms, tips and tactics.
Session 4: Primer on Discharging IRS Debt in Bankruptcy - Your client may be broke now, but made money at one time. The IRS is knocking at the door and (not-so-shockingly) wants to get paid. Learn the four basic "rules" and other "fun" facts about discharging taxes.
Session 5: Practical Considerations for Consumer Attorneys - Increase the chances of the debtor successfully completing their case. Listen to a discussion on how to create a debtor’s savings plan, increase the disbursements from the trustee for attorney fees, structure the best plan for the debtor, bankruptcy planning, ethical considerations and more. more »
Session 1: Hot Topics in Hatch-Waxman, Pharmaceuticals, and Life Sciences Patent Litigation - An overview of recent decisions in Hatch-Waxman, pharmaceuticals, and life sciences patent cases, plus trends that have developed due to those decisions.
Session 2: Case Law and Regulatory Antitrust Developments Post-Actavis - Complaints about drug prices have lead to expansion of antitrust problems for Pharma. Legislation has imposed new government reporting requirements for patent licenses in the Pharma industry. Other legislation is pending to impose new antitrust risks and penalties on the Pharma industry. Case law on “reverse settlements” has snowballed since FTC v. Actavis, and now reaches even non-cash settlement terms. Standard-setting has now become a part of the Pharma and medical device industry, bringing with it disclosure, FRAND and antitrust issues. Hear more on enacted and pending legislation, case law developments, and future trends in antitrust in the Pharma Industry. more »
Companies are investing heavily in Artificial Intelligence and Machine Learning technologies with vast arrays of applications of Neural Networks to perform complex tasks with great speed with the advent of 5G wireless technologies and stronger processing capabilities. This panel explores the components of AI/ML technologies, its applications, and how intellectual rights in these technologies can be protected including patent prosecution and data administration strategies. In addition, ethical concerns are raised as to the extent such technologies test the bounds of privacy and supplant human activities and we also explore these concerns. more »
The financial aspects of intellectual property litigation can impact the health of a business and be case determinative. Explore two important avenues for addressing and overcoming risks that may lead to better economics and better outcomes. more »
Addressing arbitration in bankruptcy including (a) a review of recent decisions regarding the enforceability of mandatory arbitration provisions and their potential application in the bankruptcy world, and (b) an overview of the mechanics of arbitration and creative utilization of arbitration in bankruptcy. more »
Hear an overview of the ITC jurisprudence over the last several years, with a discussion of recent cases that have had an impact on the ITC practice, and examine the intersection of the ITC with other government agencies, such as the PTAB, CBP, and the CIT. more »
A discussion of recent developments influencing the scope of compensation available for patent infringement, including geographic limitations on damages, SEPs and FRAND, and managing your willfulness witness. more »
Open source software development and standards development are converging, but come from disparate development traditions or freewheeling copyright licensing and deliberate patent cross licensing. How can the two work together? Examine the landscape that is coming as the two collide—or comingle. more »
Once infamously branded a “death squad” for patents, the PTAB can be a scary place for patentees faced with petitions for post-grant review. Examine PTAB-proofing techniques that patent practitioners should consider at each stage of the application drafting and prosecution process. more »
Session 1: PTAB Update - Hear an update on PTAB appeals and trial proceedings.
Session 2: The Evolution of the PTAB in the Last Year - Between new proposed amendment procedures, updates to the Patent Trial Practice Guide, and numerous precedential decisions, PTAB trial practice has experienced dramatic changes in the past year. Panelists discuss the impact of these changes and how parties on both sides of the proceedings can most effectively deal with such a rapidly evolving area of law. more »
Session 1: Recent Developments - If this distinguished panel doesn’t mention it, it just may not be worth mentioning. The year’s most important business and consumer cases.
Session 2: Recent Developments II - A more in-depth look at the best of the best (and worst of the worst).
Session 3: Increased U.S. Trustee Fees: As Inevitable as Death and Taxes? - A discussion about reining in Congressionally mandated highway robbery based on uniformity and retroactivity; issues regarding the definition of disbursements; strategies to avoid the increased fees; and judicial activism.
Session 4: Alix/McKinsey - Explore the dispute about Rule 2014 and sections 101(14) and 327. more »
Session 1: Alice at Five: Section 101 Update - Five years ago, the Supreme Court’s Alice decision significantly changed the landscape for patent eligible subject matter. Has the sky fallen? Has the pendulum swung back towards more eligibility for computer software and life sciences patents? And what will Congress do about it all? Hear the latest Section 101 developments, including recent cases, legislative proposals, and their implications and best practices for patent prosecutors and litigators.
Session 2: Section 101 in Two Realms: Where We Are and Where We Might Be Going in Life Sciences and in Software - Gain practical prosecution suggestions based on the current PTO guidelines and developing case law as they are meeting the real world in bio/pharma and in software/business methods. Plus, explore current efforts to change the law through Congress, as well as issues in enforcement. more »